Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA
Biotech
Valerio ends all clinical activity, shuts down US site
Valerio is ending all clinical trials, including an ongoing phase 1/2 study for its “DNA decoy” candidate designed to treat recurrent solid tumors.
Gabrielle Masson
Feb 4, 2025 12:09pm
Merck snaps up preclinical DNA biotech for $1.3B biobucks
Oct 23, 2024 7:05am
Eli Lilly opens $700M nucleic acid R&D center in Boston Seaport
Aug 13, 2024 9:32am
Rome's 'dark genome' drug reduces autoimmune markers in mice
Nov 17, 2023 1:03pm
Inovio drafts accelerated approval talking points for FDA visit
Nov 10, 2023 7:28am
Inovio says no-go on phase 3 program, lays off 30% of staff
Aug 10, 2023 8:00am